News
AVDL
21.64
0.00%
0.00
Alkermes Completes Acquisition and Delisting of Avadel Pharmaceuticals
TipRanks · 02/12 12:57
Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
Barchart · 02/12 06:30
After Hours Most Active for Feb 11, 2026 : PANW, DCH, RIG, FSLY, AVDL, CSCO, GRAB, NVDA, F, T, RNG, AMCR
NASDAQ · 02/12 00:59
Irish High Court sanctions Avadel Pharmaceuticals acquisition by Alkermes
TipRanks · 02/10 21:50
Weekly Report: what happened at AVDL last week (0202-0206)?
Weekly Report · 02/09 09:47
Harmony Biosciences Makes The Grade
Seeking Alpha · 02/02 20:47
Weekly Report: what happened at AVDL last week (0126-0130)?
Weekly Report · 02/02 09:46
Weekly Report: what happened at AVDL last week (0119-0123)?
Weekly Report · 01/26 09:47
Avadel Sets Court Date for Alkermes Acquisition Scheme
TipRanks · 01/20 11:37
Weekly Report: what happened at AVDL last week (0112-0116)?
Weekly Report · 01/19 09:51
Avadel Shareholders Approve Acquisition by Alkermes plc
TipRanks · 01/12 21:32
Avadel Pharmaceuticals shareholders approve acquisition by Alkermes
TipRanks · 01/12 21:31
Avadel Pharmaceuticals Shareholders Approve Proposed Takeover By Alkermes
Benzinga · 01/12 21:08
Weekly Report: what happened at AVDL last week (0105-0109)?
Weekly Report · 01/12 09:49
Catalyst Watch: Big bank earnings, major healthcare + retail conferences, Fedspeak flurry, CPI
Seeking Alpha · 01/09 20:00
Do Options Traders Know Something About Avadel Pharmaceuticals Stock We Don't?
NASDAQ · 01/09 13:32
Weekly Report: what happened at AVDL last week (1229-0102)?
Weekly Report · 01/05 09:46
Weekly Report: what happened at AVDL last week (1222-1226)?
Weekly Report · 12/29/2025 09:45
Regencell Bioscience is the top performing pharma stock YTD
Seeking Alpha · 12/23/2025 04:47
Weekly Report: what happened at AVDL last week (1215-1219)?
Weekly Report · 12/22/2025 09:45
More
Webull provides a variety of real-time AVDL stock news. You can receive the latest news about Avadel Pharmaceu through multiple platforms. This information may help you make smarter investment decisions.
About AVDL
Avadel Pharmaceuticals PLC is a biopharmaceutical company. The Company's product, LUMRYZ, is an extended-release formulation of sodium oxybate, indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. Its approach includes applying solutions to the development of medications that address the challenges patients face with treatment options. Its drug delivery technologies include MICROPUMP, LIQUITIME, and MEDUSA. Its MICROPUMP technology allows for the development of modified-release solid, oral dosage formulations of drugs. Its LIQUITIME technology allows for the development of modified-release oral products in a liquid suspension formulation, which may make such formulations particularly suited for children and/or patients having issues swallowing tablets or capsules. Its MEDUSA technology allows for the development of modified-release injectable dosage formulations of drugs.